Elamipretide vs Cetrorelix
Head-to-head comparison of Elamipretide (Elamipretide (MTP-131, SS-31)) and Cetrorelix (Cetrorelix acetate) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Elamipretide | Cetrorelix |
|---|---|---|
| Category | Muscle & Performance | Sexual Health |
| Full Name | Elamipretide (MTP-131, SS-31) | Cetrorelix acetate |
| Molecular Weight | 639.8 Da | 1431.06 Da |
| Half-Life | 1-4 hours | ~30 hours |
| Amino Acids | 4 | 10 |
| Typical Dose | 0.01-0.25 mg/kg/day | 0.25 mg SC daily |
| Route | Subcutaneous/Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 300 |
| Research Status | Clinical | Clinical |
Elamipretide Benefits
- ✓mitochondrial protection
- ✓reduced oxidative stress
- ✓improved fatigue resistance
- ✓may support exercise tolerance
Cetrorelix Benefits
- ✓prevents premature ovulation
- ✓supports IVF cycle control
- ✓blocks LH surge
- ✓short-acting pituitary suppression
Elamipretide Dosing
0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies
Cetrorelix Dosing
0.25 mg SC daily|start on stimulation day 5-6|protocol-dependent antagonist cycle
Elamipretide Side Effects
- ⚠nausea
- ⚠injection-site reactions
- ⚠diarrhea
- ⚠headache
Cetrorelix Side Effects
- ⚠injection-site reactions
- ⚠headache
- ⚠nausea
Research Overview
Elamipretide
Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.
Cetrorelix
Cetrorelix is a cornerstone GnRH antagonist in assisted reproduction, with a fast onset and reversible suppression of LH. Trials show it improves cycle management by reducing premature ovulation during stimulation.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.